Vancomycin-Resistant Enterococcus faecium Osteomyelitis: Successful Treatment With Quinupristin-Dalfopristi

South Med J. 2001;94(3) 

In This Article

Abstract and Introduction

Vancomycin-resistant enterococci (VRE) have recently emerged as an increasing concern in the management of severe infections. Treatment of these life-threatening infections has been limited to quinupristin-dalfopristin and, more recently, linezolid therapy. We report the first case, to our knowledge, of vancomycin-resistant Enterococcus faecium vertebral osteomyelitis treated successfully with quinupristin-dalfopristin. We review the recent epidemiology of VRE and briefly outline the pharmacology and pharmacokinetics of quinupristin-dalfopristin.

Multiple drug resistance is rapidly becoming an obstacle in the treatment of infection.[1] The first reports of VRE appeared in the mid-1980s and since then have increased dramatically.[2,3,4] To our knowledge, there have been no reported cases of vancomycin-resistant Enterococcus faecium osteomyelitis treated with quinupristin-dalfopristin (Synercid). However, a pharmaceutical company has reportedly treated 8 patients who had osteomyelitis and VRE, with only one failure recorded.*

Due to its intrinsic resistance, treatment of VRE osteomyelitis is extremely difficult and may require a combination of aggressive surgical debridement, hardware removal (at times), and appropriate antimicrobial therapy. We present a case of VRE (E faecium) osteomyelitis after decompressive laminectomy that was treated successfully with quinupristin-dalfopristin. The epidemiology and microbiology of VRE and the pharmacokinetics of quinupristin-dalfopristin are reviewed. Our case adds to the available data and suggests that quinupristin-dalfopristin is a useful drug in the management of these infections.

* Written communication, Maria Popp, RN, Adventis Pharmaceuticals, January 1999.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: